Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-35.80M
↓ 176% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-12.98M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-35.80M | -141.7% |
| 2024 | $-14.81M | -150.9% |
| 2023 | $-5.90M | +50.9% |
| 2022 | $-12.02M | -10.6% |
| 2021 | $-10.86M | -17.1% |
| 2020 | $-9.28M | -22.7% |
| 2019 | $-7.56M | -37.3% |
| 2018 | $-5.51M | +54.7% |
| 2017 | $-12.15M | +23.5% |
| 2016 | $-15.87M | - |